Pfizer launches DTC service for migraine, COVID drugs
The platform is similar in concept to a service launched this year by Eli Lilly, and aims to give consumers easier access to Pfizer’s migraine, COVID-19 and flu treatments.
The platform is similar in concept to a service launched this year by Eli Lilly, and aims to give consumers easier access to Pfizer’s migraine, COVID-19 and flu treatments.
If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research.
The 13-week program will offer funding and guidance to up to 12 health tech, medtech and biotech startups working on AI tools.
A looming change to how Johnson & Johnson pays out discounts to 340B-eligible drugs has hospitals — and the government — crying foul.
Organizations can reap bigger benefits from AI with guardrails and effective risk management strategies.
Facilities reported challenges hiring and retaining qualified infection prevention personnel, according to the analysis by the HHS’ Office of Inspector General.
The closures are a “tragic result of greed-driven hospital executives, backed by private equity, who prioritize their yachts and private jets over patient care,” said an Ohio nurse union leader.
The approval of both vaccines, designed to better match the coronavirus strains currently circulating, comes just ahead of the fall and winter seasons.
Nearly one-third of nurses experiencing burnout said their electronic health record contributed to symptoms, according to Klas Research. Many of those nurses reported they’d likely leave their workplaces soon.
The most common complaints against providers were for surprise billing, while the top complaints for health plans included incorrectly calculating qualifying payment amounts.